2cureX AB (publ) (STO:2CUREX)
3.770
-0.060 (-1.57%)
Jul 4, 2025, 5:18 PM CET
2cureX AB Revenue
2cureX AB had revenue of 250.00K SEK in the quarter ending June 30, 2024, a decrease of -63.07%. This brings the company's revenue in the last twelve months to 1.98M, down -49.75% year-over-year. In the year 2023, 2cureX AB had annual revenue of 2.95M, down -12.53%.
Revenue (ttm)
1.98M
Revenue Growth
-49.75%
P/S Ratio
47.89
Revenue / Employee
141.14K
Employees
14
Market Cap
94.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.95M | -422.00K | -12.53% |
Dec 31, 2022 | 3.37M | -4.02M | -54.42% |
Dec 31, 2021 | 7.39M | -8.00M | -51.98% |
Dec 31, 2020 | 15.39M | 3.41M | 28.45% |
Dec 31, 2019 | 11.98M | 4.31M | 56.12% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |